MedTrace Logo

Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder

NCT05560529 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-01-29

No results posted yet for this study

Summary

Binge eating disorder (BED) is one of the recently acknowledged eating disorders, with many theories underlying its pathology whether biological or psychological. From the biological perspective, changes in plasma ghrelin were hypothesized to have a major role in developing and maintaining the disorder, while from the psychopathological perspectives, abnormalities in emotion regulation were found in many patients.

Since Dialectical Behavioral Therapy (DBT) is known to target emotion dysregulation, the main aim of this study is to assess the efficacy of DBT versus treatment as usual (TAU) in BED patients, and whether plasma ghrelin level will be affected after treatment in both arms.

Conditions

  • Binge Eating Disorder

Interventions

BEHAVIORAL

DBT

Applying DBT modules in group format over 20 weeks

DRUG

TAU

Giving TAU (usual pharmacotherapy in BED) over 20 weeks

DIAGNOSTIC_TEST

Plasma Ghrelin

Measuring fasting plasma ghrelin pre and post treatment in both arms

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-06-15
Completion
2024-09-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05560529 on ClinicalTrials.gov